HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oxotremorine-induced cerebral hyperemia does not predict infarction volume in spontaneously hypertensive or stroke-prone rats.

AbstractOBJECTIVES:
We tested the following hypotheses: a) spontaneously hypertensive stroke-prone rats (SHR-SP) have more brain injury than spontaneously hypertensive rats (SHR) and normotensive controls (Wistar-Kyoto rats [WKY]) when exposed to transient focal ischemia; b) infarction size is not correlated with baseline blood pressure; and c) infarction size is inversely related to the cerebral hyperemic response to oxotremorine, a muscarinic agonist that increases cerebral blood flow (CBF) by stimulating endothelial nitric oxide synthase.
DESIGN:
In vivo study.
SETTING:
Animal laboratory in a university teaching hospital.
SUBJECTS:
Adult age-matched male WKY, SHR, and SHR-SP.
INTERVENTIONS:
Rats were instrumented under halothane anesthesia. Transient focal cerebral ischemia was produced for 2 hrs with the intravascular suture technique. Cerebral perfusion, estimated with laser Doppler flowmetry (LD-CBF), in response to intravenous oxotremorine, was measured in one cohort of rats to estimate endothelial nitric oxide synthase function. Infarction volume was measured at 22 hrs of reperfusion with 2,3,5-triphenyltetrazolium chloride staining.
MEASUREMENTS AND MAIN RESULTS:
Infarction volume in the striatum of SHR-SP (42+/-4 mm3) was greater than in SHR (29+/-6 mm3) or WKY (1+/-1 mm3) (n = 9 rats/strain). Resting (unanesthetized) mean arterial blood pressure was similar in SHR-SP (177+/-5 mm Hg) and SHR (170+/-5 mm Hg) despite a greater infarction volume in SHR-SP (n = 4) compared with SHR (n = 5). The percentage increase in LD-CBF signal in response to oxotremorine was similar for both groups (SHR, 64%+/-22% [n = 10]; SHR-SP, 69%+/-22% [n = 8]). However, in this cohort, cortical infarction volume was less in SHR (30%+/-4% of ipsilateral cortex) than in SHR-SP (49%+/-2% of ipsilateral cortex).
CONCLUSIONS:
Although SHR-SP have greater infarction volume than SHR, the mechanism of injury does not appear to be related to a difference in unanesthetized baseline mean arterial blood pressure or to an alteration in endothelium-produced nitric oxide.
AuthorsI Harukuni, H Takahashi, R J Traystman, A Bhardwaj, J R Kirsch
JournalCritical care medicine (Crit Care Med) Vol. 28 Issue 1 Pg. 190-5 (Jan 2000) ISSN: 0090-3493 [Print] United States
PMID10667521 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Coloring Agents
  • Muscarinic Agonists
  • Oxotremorine
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type III
  • Nos3 protein, rat
Topics
  • Animals
  • Brain (blood supply)
  • Brain Ischemia (complications, diagnostic imaging, pathology)
  • Cerebral Infarction (complications, diagnostic imaging, pathology)
  • Coloring Agents
  • Disease Models, Animal
  • Endothelium, Vascular (drug effects, enzymology)
  • Hypertension (complications)
  • Laser-Doppler Flowmetry
  • Male
  • Muscarinic Agonists (pharmacology)
  • Nitric Oxide Synthase (drug effects)
  • Nitric Oxide Synthase Type III
  • Oxotremorine (pharmacology)
  • Predictive Value of Tests
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred Strains
  • Rats, Inbred WKY
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: